Works matching IS 09147187 AND DT 2025 AND VI 39 AND IP 4

Results: 11

Correction: Generative AI and large language models in nuclear medicine: current status and future prospects.
Published in:
2025
By:
- Hirata, Kenji;
- Matsui, Yusuke;
- Yamada, Akira;
- Fujioka, Tomoyuki;
- Yanagawa, Masahiro;
- Nakaura, Takeshi;
- Ito, Rintaro;
- Ueda, Daiju;
- Fujita, Shohei;
- Tatsugami, Fuminari;
- Fushimi, Yasutaka;
- Tsuboyama, Takahiro;
- Kamagata, Koji;
- Nozaki, Taiki;
- Fujima, Noriyuki;
- Kawamura, Mariko;
- Naganawa, Shinji
Publication type:
Correction Notice
Specific molecular imaging of BALB/c model mice with Graves' ophthalmopathy based on high expression of insulin-like growth factor 1 receptor.
Published in:
Annals of Nuclear Medicine, 2025, v. 39, n. 4, p. 388, doi. 10.1007/s12149-024-02013-4
By:
- Zhang, Zhiting;
- Ma, Ziyu;
- Wang, Xuan;
- Zhou, Yaqian;
- Wu, Ruixin;
- Shen, Yiming;
- Li, Ning;
- Jia, Qiang;
- Zhang, Hong;
- Li, Wei;
- Zheng, Wei
Publication type:
Article
First study on the efficiency of 99mTc-rituximab for sentinel lymph node mapping and biopsy in oral squamous cell carcinoma.
Published in:
Annals of Nuclear Medicine, 2025, v. 39, n. 4, p. 380, doi. 10.1007/s12149-024-02012-5
By:
- Liu, Yang;
- Wang, Fei;
- Song, Yufei;
- Zhou, Xiaochuan;
- Zhou, Xin;
- Du, Changzhi;
- Cui, Yan;
- Liu, Yitong;
- Li, Nan
Publication type:
Article
Comparing laboratory toxicity of selective intra-arterial radionuclide therapy for primary and metastatic liver tumors: resin versus glass microspheres.
Published in:
Annals of Nuclear Medicine, 2025, v. 39, n. 4, p. 373, doi. 10.1007/s12149-024-02011-6
By:
- Soydaş-Turan, Başak;
- Bozkurt, M. Fani;
- Eldem, Gonca;
- Peynircioglu, Bora;
- Ugur, Omer;
- Volkan-Salanci, Bilge
Publication type:
Article
Imaging of cardiac amyloidosis using dynamic 18F-FPYBF-2 positron emission tomography.
Published in:
Annals of Nuclear Medicine, 2025, v. 39, n. 4, p. 398, doi. 10.1007/s12149-024-02010-7
By:
- Okuyama, Chio;
- Inuzuka, Yasutaka;
- Takeuchi, Yuzo;
- Asagoe, Kohsuke;
- Kagawa, Shinya;
- Ito, Miki;
- Kusano, Kuninori;
- Fujita, Yoshiharu;
- Watanabe, Hiroyuki;
- Ono, Masahiro;
- Higashi, Tatsuya
Publication type:
Article
Radiolabelled anti-PD-L1 peptide PET/CT in predicting the efficacy of neoadjuvant immunotherapy combined with chemotherapy in resectable non-small cell lung cancer.
Published in:
Annals of Nuclear Medicine, 2025, v. 39, n. 4, p. 364, doi. 10.1007/s12149-024-02009-0
By:
- Zhou, Xin;
- Yan, Shi;
- Li, Dan;
- Zhu, Hua;
- Liu, Bing;
- Liu, Shiwei;
- Zhao, Wei;
- Yang, Zhi;
- Wu, Nan;
- Li, Nan
Publication type:
Article
Application of modified Curie and SIOPEN skeleton scoring systems in 18F-AlF-NOTA-octreotide PET/CT for neuroblastoma.
Published in:
Annals of Nuclear Medicine, 2025, v. 39, n. 4, p. 353, doi. 10.1007/s12149-024-02006-3
By:
- Li, Siqi;
- Sang, Baojun;
- Liu, Jun;
- Liu, Yuxuan;
- Xu, Yanfeng;
- Sun, Xiaorong;
- Yang, Jigang
Publication type:
Article
18F-FET PET/CT can aid in diagnosing patients with indeterminate MRI findings for brain tumors: a prospective study.
Published in:
Annals of Nuclear Medicine, 2025, v. 39, n. 4, p. 342, doi. 10.1007/s12149-024-02005-4
By:
- Chan, Sheng-Chieh;
- Chiu, Tsung-Lang;
- Ng, Shu-Hang;
- Kao, Hung-Wen;
- Tsai, Sheng-Tzung;
- Liu, Shu-Hsin
Publication type:
Article
PRIMARY scoring in 68Ga-PSMA PET/CT: correlation with prostate cancer risk groups and its potential impact on active surveillance.
Published in:
Annals of Nuclear Medicine, 2025, v. 39, n. 4, p. 334, doi. 10.1007/s12149-024-02004-5
By:
- Uslu, Hatice;
- Şahin, Dilruba;
- İbişoğlu, Ebru;
- Tatoğlu, Mehmet Tarık
Publication type:
Article
Improvement of tumor-to-blood ratio of radioimmunoconjugates by poly(ethyleneimine)-containing chelating agent.
Published in:
Annals of Nuclear Medicine, 2025, v. 39, n. 4, p. 323, doi. 10.1007/s12149-024-02003-6
By:
- Nakashima, Kazuma;
- Shimohara, Hiroki;
- Watanabe, Hiroyuki;
- Ono, Masahiro
Publication type:
Article
Predictive value of 18F-fluorodeoxyglucose uptake for axillary lymph node metastasis in operable breast cancer: impact of molecular subtypes.
Published in:
Annals of Nuclear Medicine, 2025, v. 39, n. 4, p. 315, doi. 10.1007/s12149-024-02002-7
By:
- Lim, Chae Hong;
- Lee, Jun-Hee;
- Lee, Jihyoun;
- Park, Soo Bin
Publication type:
Article

Works matching IS 09147187 AND DT 2025 AND VI 39 AND IP 4

Correction: Generative AI and large language models in nuclear medicine: current status and future prospects.

Specific molecular imaging of BALB/c model mice with Graves' ophthalmopathy based on high expression of insulin-like growth factor 1 receptor.

First study on the efficiency of <sup>99m</sup>Tc-rituximab for sentinel lymph node mapping and biopsy in oral squamous cell carcinoma.

Comparing laboratory toxicity of selective intra-arterial radionuclide therapy for primary and metastatic liver tumors: resin versus glass microspheres.

Imaging of cardiac amyloidosis using dynamic <sup>18</sup>F-FPYBF-2 positron emission tomography.

Radiolabelled anti-PD-L1 peptide PET/CT in predicting the efficacy of neoadjuvant immunotherapy combined with chemotherapy in resectable non-small cell lung cancer.

Application of modified Curie and SIOPEN skeleton scoring systems in <sup>18</sup>F-AlF-NOTA-octreotide PET/CT for neuroblastoma.

<sup>18</sup>F-FET PET/CT can aid in diagnosing patients with indeterminate MRI findings for brain tumors: a prospective study.

PRIMARY scoring in 68Ga-PSMA PET/CT: correlation with prostate cancer risk groups and its potential impact on active surveillance.

Improvement of tumor-to-blood ratio of radioimmunoconjugates by poly(ethyleneimine)-containing chelating agent.

Predictive value of <sup>18</sup>F-fluorodeoxyglucose uptake for axillary lymph node metastasis in operable breast cancer: impact of molecular subtypes.